Pediatric Vaccines Market Research Report by Technology (Attenuated Live Viruses, Conjugates, Inactivated Viruses, Polysaccharides, and Recombinant), by Vaccine Type (Monovalent and Multivalent), by End User, by Indication - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Pediatric Vaccines Market is expected to grow from USD 13,856.16 Million in 2020 to USD 22,869.61 Million by the end of 2025.
2. The Global Pediatric Vaccines Market is expected to grow from EUR 12,149.35 Million in 2020 to EUR 20,052.51 Million by the end of 2025.
3. The Global Pediatric Vaccines Market is expected to grow from GBP 10,800.80 Million in 2020 to GBP 17,826.73 Million by the end of 2025.
4. The Global Pediatric Vaccines Market is expected to grow from JPY 1,478,804.27 Million in 2020 to JPY 2,440,767.92 Million by the end of 2025.
5. The Global Pediatric Vaccines Market is expected to grow from AUD 20,120.99 Million in 2020 to AUD 33,209.72 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Pediatric Vaccines to forecast the revenues and analyze the trends in each of the following sub-markets:
'The Conjugates is projected to witness the highest growth during the forecast period'
Based on Technology, the Pediatric Vaccines Market studied across Attenuated Live Viruses, Conjugates, Inactivated Viruses, Polysaccharides, Recombinant, Subunits, and Toxoids. The Attenuated Live Viruses commanded the largest size in the Pediatric Vaccines Market in 2020. On the other hand, the Conjugates is expected to grow at the fastest CAGR during the forecast period.
'The Multivalent is projected to witness the highest growth during the forecast period'
Based on Vaccine Type, the Pediatric Vaccines Market studied across Monovalent and Multivalent. The Multivalent commanded the largest size in the Pediatric Vaccines Market in 2020, and it is expected to grow at the fastest CAGR during the forecast period.
'The Pediatric Clinic is projected to witness the highest growth during the forecast period'
Based on End User, the Pediatric Vaccines Market studied across Hospital, Pediatric Clinic, and Research Organization. The Pediatric Clinic commanded the largest size in the Pediatric Vaccines Market in 2020, and it is expected to grow at the fastest CAGR during the forecast period.
'The Haemophilus Influenzae Type B is projected to witness the highest growth during the forecast period'
Based on Indication, the Pediatric Vaccines Market studied across Haemophilus Influenzae Type B, Hepatitis, Human papillomavirus (HPV), Measles, Meningitis A, Mumps, Pneumococcal Diseases, Polio, Rotaviruses, Rubella, Tetanus, and Yellow Fever. The Pneumococcal Diseases commanded the largest size in the Pediatric Vaccines Market in 2020. On the other hand, the Haemophilus Influenzae Type B is expected to grow at the fastest CAGR during the forecast period.
'The Asia-Pacific is projected to witness the highest growth during the forecast period'
Based on Geography, the Pediatric Vaccines Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded the largest size in the Pediatric Vaccines Market in 2020. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Pediatric Vaccines Market including AstraZeneca PLC, CSL Limited, Eli Lilly and Company, GlaxoSmithKline PLC, Merck Sharp & Dohme Corp., Mitsubishi Chemical Corporation, Novartis AG, Pfizer Inc., Sanofi S.A., and Serum Institute of India Pvt. Ltd..
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Pediatric Vaccines Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Pediatric Vaccines Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Pediatric Vaccines Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Pediatric Vaccines Market?
4. What is the competitive strategic window for opportunities in the Global Pediatric Vaccines Market?
5. What are the technology trends and regulatory frameworks in the Global Pediatric Vaccines Market?
6. What are the modes and strategic moves considered suitable for entering the Global Pediatric Vaccines Market?
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Pediatric Vaccines Market is expected to grow from USD 13,856.16 Million in 2020 to USD 22,869.61 Million by the end of 2025.
2. The Global Pediatric Vaccines Market is expected to grow from EUR 12,149.35 Million in 2020 to EUR 20,052.51 Million by the end of 2025.
3. The Global Pediatric Vaccines Market is expected to grow from GBP 10,800.80 Million in 2020 to GBP 17,826.73 Million by the end of 2025.
4. The Global Pediatric Vaccines Market is expected to grow from JPY 1,478,804.27 Million in 2020 to JPY 2,440,767.92 Million by the end of 2025.
5. The Global Pediatric Vaccines Market is expected to grow from AUD 20,120.99 Million in 2020 to AUD 33,209.72 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Pediatric Vaccines to forecast the revenues and analyze the trends in each of the following sub-markets:
'The Conjugates is projected to witness the highest growth during the forecast period'
Based on Technology, the Pediatric Vaccines Market studied across Attenuated Live Viruses, Conjugates, Inactivated Viruses, Polysaccharides, Recombinant, Subunits, and Toxoids. The Attenuated Live Viruses commanded the largest size in the Pediatric Vaccines Market in 2020. On the other hand, the Conjugates is expected to grow at the fastest CAGR during the forecast period.
'The Multivalent is projected to witness the highest growth during the forecast period'
Based on Vaccine Type, the Pediatric Vaccines Market studied across Monovalent and Multivalent. The Multivalent commanded the largest size in the Pediatric Vaccines Market in 2020, and it is expected to grow at the fastest CAGR during the forecast period.
'The Pediatric Clinic is projected to witness the highest growth during the forecast period'
Based on End User, the Pediatric Vaccines Market studied across Hospital, Pediatric Clinic, and Research Organization. The Pediatric Clinic commanded the largest size in the Pediatric Vaccines Market in 2020, and it is expected to grow at the fastest CAGR during the forecast period.
'The Haemophilus Influenzae Type B is projected to witness the highest growth during the forecast period'
Based on Indication, the Pediatric Vaccines Market studied across Haemophilus Influenzae Type B, Hepatitis, Human papillomavirus (HPV), Measles, Meningitis A, Mumps, Pneumococcal Diseases, Polio, Rotaviruses, Rubella, Tetanus, and Yellow Fever. The Pneumococcal Diseases commanded the largest size in the Pediatric Vaccines Market in 2020. On the other hand, the Haemophilus Influenzae Type B is expected to grow at the fastest CAGR during the forecast period.
'The Asia-Pacific is projected to witness the highest growth during the forecast period'
Based on Geography, the Pediatric Vaccines Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded the largest size in the Pediatric Vaccines Market in 2020. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Pediatric Vaccines Market including AstraZeneca PLC, CSL Limited, Eli Lilly and Company, GlaxoSmithKline PLC, Merck Sharp & Dohme Corp., Mitsubishi Chemical Corporation, Novartis AG, Pfizer Inc., Sanofi S.A., and Serum Institute of India Pvt. Ltd..
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Pediatric Vaccines Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Pediatric Vaccines Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Pediatric Vaccines Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Pediatric Vaccines Market?
4. What is the competitive strategic window for opportunities in the Global Pediatric Vaccines Market?
5. What are the technology trends and regulatory frameworks in the Global Pediatric Vaccines Market?
6. What are the modes and strategic moves considered suitable for entering the Global Pediatric Vaccines Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Technology Outlook
3.4. Vaccine Type Outlook
3.5. Indication Outlook
3.6. End User Outlook
3.7. Geography Outlook
3.8. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of infectious diseases in the pediatric population
5.1.1.2. Benefits of immunizations like protection from serious diseases prevention and the spread of those diseases to others
5.1.1.3. Government intervention for the use of pediatric vaccines
5.1.2. Restraints
5.1.2.1. Lack of implementation of mandatory vaccination
5.1.2.2. Slight-side effects associated with pediatric vaccines
5.1.3. Opportunities
5.1.3.1. Strong late-stage pipeline and new drug approvals
5.1.3.2. Routinized vaccines used in immunization of infants and children
5.1.4. Challenges
5.1.4.1. No uniform recall or reminder system and staff shortages
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL PEDIATRIC VACCINES MARKET, BY TECHNOLOGY
6.1. Introduction
6.2. Attenuated Live Viruses
6.3. Conjugates
6.4. Inactivated Viruses
6.5. Polysaccharides
6.6. Recombinant
6.7. Subunits
6.8. Toxoids
7. GLOBAL PEDIATRIC VACCINES MARKET, BY VACCINE TYPE
7.1. Introduction
7.2. Monovalent
7.3. Multivalent
8. GLOBAL PEDIATRIC VACCINES MARKET, BY END USER
8.1. Introduction
8.2. Hospital
8.3. Pediatric Clinic
8.4. Research Organization
9. GLOBAL PEDIATRIC VACCINES MARKET, BY INDICATION
9.1. Introduction
9.2. Haemophilus Influenzae Type B
9.3. Hepatitis
9.4. Human papillomavirus (HPV)
9.5. Measles
9.6. Meningitis A
9.7. Mumps
9.8. Pneumococcal Diseases
9.9. Polio
9.10. Rotaviruses
9.11. Rubella
9.12. Tetanus
9.13. Yellow Fever
10. AMERICAS PEDIATRIC VACCINES MARKET
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. ASIA-PACIFIC PEDIATRIC VACCINES MARKET
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. South Korea
11.10. Thailand
12. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom
13. COMPETITIVE LANDSCAPE
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis
13.4. Competitor SWOT Analysis
13.5. Competitive Scenario
13.5.1. Merger & Acquisition
13.5.2. Agreement, Collaboration, & Partnership
13.5.3. New Product Launch & Enhancement
13.5.4. Investment & Funding
13.5.5. Award, Recognition, & Expansion
14. COMPANY USABILITY PROFILES
14.1. AstraZeneca PLC
14.2. CSL Limited
14.3. Eli Lilly and Company
14.4. GlaxoSmithKline PLC
14.5. Merck Sharp & Dohme Corp.
14.6. Mitsubishi Chemical Corporation
14.7. Novartis AG
14.8. Pfizer Inc.
14.9. Sanofi S.A.
14.10. Serum Institute of India Pvt. Ltd.
15. APPENDIX
15.1. Discussion Guide
15.2. License & Pricing
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Technology Outlook
3.4. Vaccine Type Outlook
3.5. Indication Outlook
3.6. End User Outlook
3.7. Geography Outlook
3.8. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of infectious diseases in the pediatric population
5.1.1.2. Benefits of immunizations like protection from serious diseases prevention and the spread of those diseases to others
5.1.1.3. Government intervention for the use of pediatric vaccines
5.1.2. Restraints
5.1.2.1. Lack of implementation of mandatory vaccination
5.1.2.2. Slight-side effects associated with pediatric vaccines
5.1.3. Opportunities
5.1.3.1. Strong late-stage pipeline and new drug approvals
5.1.3.2. Routinized vaccines used in immunization of infants and children
5.1.4. Challenges
5.1.4.1. No uniform recall or reminder system and staff shortages
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL PEDIATRIC VACCINES MARKET, BY TECHNOLOGY
6.1. Introduction
6.2. Attenuated Live Viruses
6.3. Conjugates
6.4. Inactivated Viruses
6.5. Polysaccharides
6.6. Recombinant
6.7. Subunits
6.8. Toxoids
7. GLOBAL PEDIATRIC VACCINES MARKET, BY VACCINE TYPE
7.1. Introduction
7.2. Monovalent
7.3. Multivalent
8. GLOBAL PEDIATRIC VACCINES MARKET, BY END USER
8.1. Introduction
8.2. Hospital
8.3. Pediatric Clinic
8.4. Research Organization
9. GLOBAL PEDIATRIC VACCINES MARKET, BY INDICATION
9.1. Introduction
9.2. Haemophilus Influenzae Type B
9.3. Hepatitis
9.4. Human papillomavirus (HPV)
9.5. Measles
9.6. Meningitis A
9.7. Mumps
9.8. Pneumococcal Diseases
9.9. Polio
9.10. Rotaviruses
9.11. Rubella
9.12. Tetanus
9.13. Yellow Fever
10. AMERICAS PEDIATRIC VACCINES MARKET
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. ASIA-PACIFIC PEDIATRIC VACCINES MARKET
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. South Korea
11.10. Thailand
12. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom
13. COMPETITIVE LANDSCAPE
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis
13.4. Competitor SWOT Analysis
13.5. Competitive Scenario
13.5.1. Merger & Acquisition
13.5.2. Agreement, Collaboration, & Partnership
13.5.3. New Product Launch & Enhancement
13.5.4. Investment & Funding
13.5.5. Award, Recognition, & Expansion
14. COMPANY USABILITY PROFILES
14.1. AstraZeneca PLC
14.2. CSL Limited
14.3. Eli Lilly and Company
14.4. GlaxoSmithKline PLC
14.5. Merck Sharp & Dohme Corp.
14.6. Mitsubishi Chemical Corporation
14.7. Novartis AG
14.8. Pfizer Inc.
14.9. Sanofi S.A.
14.10. Serum Institute of India Pvt. Ltd.
15. APPENDIX
15.1. Discussion Guide
15.2. License & Pricing
LIST OF TABLES
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL PEDIATRIC VACCINES MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY ATTENUATED LIVE VIRUSES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY CONJUGATES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY INACTIVATED VIRUSES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY POLYSACCHARIDES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY RECOMBINANT, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY SUBUNITS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TOXOIDS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MONOVALENT, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MULTIVALENT, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY HOSPITAL, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY PEDIATRIC CLINIC, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY RESEARCH ORGANIZATION, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY HAEMOPHILUS INFLUENZAE TYPE B, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY HEPATITIS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY HUMAN PAPILLOMAVIRUS (HPV), BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MEASLES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MENINGITIS A, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MUMPS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY PNEUMOCOCCAL DISEASES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY POLIO, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY ROTAVIRUSES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY RUBELLA, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TETANUS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY YELLOW FEVER, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. ARGENTINA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. ARGENTINA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. ARGENTINA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. ARGENTINA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. BRAZIL PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. BRAZIL PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. BRAZIL PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. BRAZIL PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. CANADA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. CANADA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. CANADA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. CANADA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. MEXICO PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. MEXICO PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. MEXICO PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. MEXICO PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. AUSTRALIA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. AUSTRALIA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. AUSTRALIA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. AUSTRALIA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. CHINA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. CHINA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. CHINA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. CHINA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. INDIA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. INDIA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. INDIA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. INDIA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. INDONESIA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. INDONESIA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. INDONESIA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. INDONESIA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. JAPAN PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. JAPAN PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. JAPAN PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. JAPAN PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. MALAYSIA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. MALAYSIA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. MALAYSIA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. MALAYSIA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. PHILIPPINES PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. PHILIPPINES PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. PHILIPPINES PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. PHILIPPINES PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. SOUTH KOREA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. SOUTH KOREA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. SOUTH KOREA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. SOUTH KOREA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. THAILAND PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. THAILAND PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. THAILAND PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. THAILAND PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. FRANCE PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. FRANCE PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. FRANCE PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 106. FRANCE PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 107. GERMANY PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 108. GERMANY PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 109. GERMANY PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 110. GERMANY PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 111. ITALY PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 112. ITALY PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 113. ITALY PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 114. ITALY PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 115. NETHERLANDS PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 116. NETHERLANDS PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 117. NETHERLANDS PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 118. NETHERLANDS PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 119. QATAR PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 120. QATAR PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 121. QATAR PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 122. QATAR PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 123. RUSSIA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 124. RUSSIA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 125. RUSSIA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 126. RUSSIA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 127. SAUDI ARABIA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 128. SAUDI ARABIA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 129. SAUDI ARABIA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 130. SAUDI ARABIA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 131. SOUTH AFRICA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 132. SOUTH AFRICA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 133. SOUTH AFRICA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 134. SOUTH AFRICA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 135. SPAIN PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 136. SPAIN PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 137. SPAIN PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 138. SPAIN PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 139. UNITED ARAB EMIRATES PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 140. UNITED ARAB EMIRATES PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 141. UNITED ARAB EMIRATES PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 142. UNITED ARAB EMIRATES PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 143. UNITED KINGDOM PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 144. UNITED KINGDOM PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 145. UNITED KINGDOM PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 146. UNITED KINGDOM PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 147. GLOBAL PEDIATRIC VACCINES MARKET: SCORES
TABLE 148. GLOBAL PEDIATRIC VACCINES MARKET: BUSINESS STRATEGY
TABLE 149. GLOBAL PEDIATRIC VACCINES MARKET: PRODUCT SATISFACTION
TABLE 150. GLOBAL PEDIATRIC VACCINES MARKET: RANKING
TABLE 151. GLOBAL PEDIATRIC VACCINES MARKET: MERGER & ACQUISITION
TABLE 152. GLOBAL PEDIATRIC VACCINES MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 153. GLOBAL PEDIATRIC VACCINES MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 154. GLOBAL PEDIATRIC VACCINES MARKET: INVESTMENT & FUNDING
TABLE 155. GLOBAL PEDIATRIC VACCINES MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 156. GLOBAL PEDIATRIC VACCINES MARKET: LICENSE & PRICING
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL PEDIATRIC VACCINES MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY ATTENUATED LIVE VIRUSES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY CONJUGATES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY INACTIVATED VIRUSES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY POLYSACCHARIDES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY RECOMBINANT, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY SUBUNITS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TOXOIDS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MONOVALENT, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MULTIVALENT, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY HOSPITAL, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY PEDIATRIC CLINIC, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY RESEARCH ORGANIZATION, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY HAEMOPHILUS INFLUENZAE TYPE B, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY HEPATITIS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY HUMAN PAPILLOMAVIRUS (HPV), BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MEASLES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MENINGITIS A, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MUMPS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY PNEUMOCOCCAL DISEASES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY POLIO, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY ROTAVIRUSES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY RUBELLA, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TETANUS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY YELLOW FEVER, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. ARGENTINA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. ARGENTINA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. ARGENTINA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. ARGENTINA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. BRAZIL PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. BRAZIL PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. BRAZIL PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. BRAZIL PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. CANADA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. CANADA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. CANADA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. CANADA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. MEXICO PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. MEXICO PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. MEXICO PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. MEXICO PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. AUSTRALIA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. AUSTRALIA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. AUSTRALIA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. AUSTRALIA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. CHINA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. CHINA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. CHINA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. CHINA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. INDIA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. INDIA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. INDIA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. INDIA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. INDONESIA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. INDONESIA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. INDONESIA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. INDONESIA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. JAPAN PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. JAPAN PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. JAPAN PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. JAPAN PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. MALAYSIA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. MALAYSIA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. MALAYSIA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. MALAYSIA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. PHILIPPINES PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. PHILIPPINES PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. PHILIPPINES PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. PHILIPPINES PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. SOUTH KOREA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. SOUTH KOREA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. SOUTH KOREA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. SOUTH KOREA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. THAILAND PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. THAILAND PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. THAILAND PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. THAILAND PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. FRANCE PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. FRANCE PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. FRANCE PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 106. FRANCE PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 107. GERMANY PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 108. GERMANY PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 109. GERMANY PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 110. GERMANY PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 111. ITALY PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 112. ITALY PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 113. ITALY PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 114. ITALY PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 115. NETHERLANDS PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 116. NETHERLANDS PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 117. NETHERLANDS PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 118. NETHERLANDS PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 119. QATAR PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 120. QATAR PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 121. QATAR PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 122. QATAR PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 123. RUSSIA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 124. RUSSIA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 125. RUSSIA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 126. RUSSIA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 127. SAUDI ARABIA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 128. SAUDI ARABIA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 129. SAUDI ARABIA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 130. SAUDI ARABIA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 131. SOUTH AFRICA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 132. SOUTH AFRICA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 133. SOUTH AFRICA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 134. SOUTH AFRICA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 135. SPAIN PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 136. SPAIN PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 137. SPAIN PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 138. SPAIN PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 139. UNITED ARAB EMIRATES PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 140. UNITED ARAB EMIRATES PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 141. UNITED ARAB EMIRATES PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 142. UNITED ARAB EMIRATES PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 143. UNITED KINGDOM PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 144. UNITED KINGDOM PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 145. UNITED KINGDOM PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 146. UNITED KINGDOM PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 147. GLOBAL PEDIATRIC VACCINES MARKET: SCORES
TABLE 148. GLOBAL PEDIATRIC VACCINES MARKET: BUSINESS STRATEGY
TABLE 149. GLOBAL PEDIATRIC VACCINES MARKET: PRODUCT SATISFACTION
TABLE 150. GLOBAL PEDIATRIC VACCINES MARKET: RANKING
TABLE 151. GLOBAL PEDIATRIC VACCINES MARKET: MERGER & ACQUISITION
TABLE 152. GLOBAL PEDIATRIC VACCINES MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 153. GLOBAL PEDIATRIC VACCINES MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 154. GLOBAL PEDIATRIC VACCINES MARKET: INVESTMENT & FUNDING
TABLE 155. GLOBAL PEDIATRIC VACCINES MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 156. GLOBAL PEDIATRIC VACCINES MARKET: LICENSE & PRICING
LIST OF FIGURES
FIGURE 1. GLOBAL PEDIATRIC VACCINES MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL PEDIATRIC VACCINES MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL PEDIATRIC VACCINES MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2020 (USD MILLION)
FIGURE 5. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2020 (USD MILLION)
FIGURE 6. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2020 (USD MILLION)
FIGURE 7. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2020 (USD MILLION)
FIGURE 8. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 9. GLOBAL PEDIATRIC VACCINES MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 10. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 11. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 12. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 13. GLOBAL PEDIATRIC VACCINES MARKET: MARKET DYNAMICS
FIGURE 14. GLOBAL PEDIATRIC VACCINES MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 15. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2020 VS 2025 (%)
FIGURE 16. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2020 VS 2025 (USD MILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2025
FIGURE 18. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY ATTENUATED LIVE VIRUSES, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY CONJUGATES, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY INACTIVATED VIRUSES, 2020 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY POLYSACCHARIDES, 2020 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY RECOMBINANT, 2020 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY SUBUNITS, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TOXOIDS, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2020 VS 2025 (%)
FIGURE 26. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 27. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2025
FIGURE 28. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MONOVALENT, 2020 VS 2025 (USD MILLION)
FIGURE 29. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MULTIVALENT, 2020 VS 2025 (USD MILLION)
FIGURE 30. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2020 VS 2025 (%)
FIGURE 31. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2020 VS 2025 (USD MILLION)
FIGURE 32. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2025
FIGURE 33. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY HOSPITAL, 2020 VS 2025 (USD MILLION)
FIGURE 34. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY PEDIATRIC CLINIC, 2020 VS 2025 (USD MILLION)
FIGURE 35. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY RESEARCH ORGANIZATION, 2020 VS 2025 (USD MILLION)
FIGURE 36. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2020 VS 2025 (%)
FIGURE 37. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2020 VS 2025 (USD MILLION)
FIGURE 38. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2025
FIGURE 39. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY HAEMOPHILUS INFLUENZAE TYPE B, 2020 VS 2025 (USD MILLION)
FIGURE 40. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY HEPATITIS, 2020 VS 2025 (USD MILLION)
FIGURE 41. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY HUMAN PAPILLOMAVIRUS (HPV), 2020 VS 2025 (USD MILLION)
FIGURE 42. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MEASLES, 2020 VS 2025 (USD MILLION)
FIGURE 43. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MENINGITIS A, 2020 VS 2025 (USD MILLION)
FIGURE 44. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MUMPS, 2020 VS 2025 (USD MILLION)
FIGURE 45. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY PNEUMOCOCCAL DISEASES, 2020 VS 2025 (USD MILLION)
FIGURE 46. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY POLIO, 2020 VS 2025 (USD MILLION)
FIGURE 47. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY ROTAVIRUSES, 2020 VS 2025 (USD MILLION)
FIGURE 48. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY RUBELLA, 2020 VS 2025 (USD MILLION)
FIGURE 49. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TETANUS, 2020 VS 2025 (USD MILLION)
FIGURE 50. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY YELLOW FEVER, 2020 VS 2025 (USD MILLION)
FIGURE 51. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 52. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 53. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 54. ARGENTINA PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 55. BRAZIL PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. CANADA PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. MEXICO PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 60. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 61. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 62. AUSTRALIA PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 63. CHINA PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. INDIA PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 65. INDONESIA PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 66. JAPAN PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 67. MALAYSIA PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 68. PHILIPPINES PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 69. SOUTH KOREA PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 70. THAILAND PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 71. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 72. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 73. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 74. FRANCE PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 75. GERMANY PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 76. ITALY PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 77. NETHERLANDS PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 78. QATAR PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 79. RUSSIA PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 80. SAUDI ARABIA PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 81. SOUTH AFRICA PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 82. SPAIN PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 83. UNITED ARAB EMIRATES PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 84. UNITED KINGDOM PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 85. GLOBAL PEDIATRIC VACCINES MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 86. GLOBAL PEDIATRIC VACCINES MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 87. GLOBAL PEDIATRIC VACCINES MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 88. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL PEDIATRIC VACCINES MARKET, BY TYPE
FIGURE 1. GLOBAL PEDIATRIC VACCINES MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL PEDIATRIC VACCINES MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL PEDIATRIC VACCINES MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2020 (USD MILLION)
FIGURE 5. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2020 (USD MILLION)
FIGURE 6. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2020 (USD MILLION)
FIGURE 7. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2020 (USD MILLION)
FIGURE 8. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 9. GLOBAL PEDIATRIC VACCINES MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 10. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 11. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 12. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 13. GLOBAL PEDIATRIC VACCINES MARKET: MARKET DYNAMICS
FIGURE 14. GLOBAL PEDIATRIC VACCINES MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 15. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2020 VS 2025 (%)
FIGURE 16. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2020 VS 2025 (USD MILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2025
FIGURE 18. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY ATTENUATED LIVE VIRUSES, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY CONJUGATES, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY INACTIVATED VIRUSES, 2020 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY POLYSACCHARIDES, 2020 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY RECOMBINANT, 2020 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY SUBUNITS, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TOXOIDS, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2020 VS 2025 (%)
FIGURE 26. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 27. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2025
FIGURE 28. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MONOVALENT, 2020 VS 2025 (USD MILLION)
FIGURE 29. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MULTIVALENT, 2020 VS 2025 (USD MILLION)
FIGURE 30. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2020 VS 2025 (%)
FIGURE 31. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2020 VS 2025 (USD MILLION)
FIGURE 32. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2025
FIGURE 33. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY HOSPITAL, 2020 VS 2025 (USD MILLION)
FIGURE 34. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY PEDIATRIC CLINIC, 2020 VS 2025 (USD MILLION)
FIGURE 35. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY RESEARCH ORGANIZATION, 2020 VS 2025 (USD MILLION)
FIGURE 36. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2020 VS 2025 (%)
FIGURE 37. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2020 VS 2025 (USD MILLION)
FIGURE 38. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2025
FIGURE 39. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY HAEMOPHILUS INFLUENZAE TYPE B, 2020 VS 2025 (USD MILLION)
FIGURE 40. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY HEPATITIS, 2020 VS 2025 (USD MILLION)
FIGURE 41. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY HUMAN PAPILLOMAVIRUS (HPV), 2020 VS 2025 (USD MILLION)
FIGURE 42. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MEASLES, 2020 VS 2025 (USD MILLION)
FIGURE 43. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MENINGITIS A, 2020 VS 2025 (USD MILLION)
FIGURE 44. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MUMPS, 2020 VS 2025 (USD MILLION)
FIGURE 45. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY PNEUMOCOCCAL DISEASES, 2020 VS 2025 (USD MILLION)
FIGURE 46. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY POLIO, 2020 VS 2025 (USD MILLION)
FIGURE 47. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY ROTAVIRUSES, 2020 VS 2025 (USD MILLION)
FIGURE 48. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY RUBELLA, 2020 VS 2025 (USD MILLION)
FIGURE 49. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TETANUS, 2020 VS 2025 (USD MILLION)
FIGURE 50. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY YELLOW FEVER, 2020 VS 2025 (USD MILLION)
FIGURE 51. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 52. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 53. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 54. ARGENTINA PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 55. BRAZIL PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. CANADA PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. MEXICO PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 60. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 61. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 62. AUSTRALIA PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 63. CHINA PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. INDIA PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 65. INDONESIA PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 66. JAPAN PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 67. MALAYSIA PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 68. PHILIPPINES PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 69. SOUTH KOREA PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 70. THAILAND PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 71. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 72. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 73. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 74. FRANCE PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 75. GERMANY PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 76. ITALY PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 77. NETHERLANDS PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 78. QATAR PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 79. RUSSIA PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 80. SAUDI ARABIA PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 81. SOUTH AFRICA PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 82. SPAIN PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 83. UNITED ARAB EMIRATES PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 84. UNITED KINGDOM PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 85. GLOBAL PEDIATRIC VACCINES MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 86. GLOBAL PEDIATRIC VACCINES MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 87. GLOBAL PEDIATRIC VACCINES MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 88. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL PEDIATRIC VACCINES MARKET, BY TYPE
